comparemela.com

Latest Breaking News On - Indivior - Page 14 : comparemela.com

Indivior completes acquisition of Opiant Pharmaceuticals

Indivior PLC - North Chesterfield, Virginia-based pharmaceutical company - Completes the acquisition of Opiant Pharmaceuticals Inc. Says the acquisition will strengthen its addiction treatment and. | March 2, 2023

United statesHeather rydingsAlliance news ltdAlliance newsOpiant pharmaceuticals incOpiant pharmaceuticalsAll rightsIndivior plc stock exchangePress releaseReatment indv gb00bn4ht335

Indivior Capital Markets Day Highlights Strategy for Shareholder Value Creation and Attractive Medium-Term Profitable Growth Outlook

- Peak Annual Net Revenue Potential for SUBLOCADE Increased to >$1.5 Billion - Attractive and Scalable Business Outlined - Expects Strong Net Revenue Growth and Operating Margin Expansion

New yorkUnited statesMark crossleyKathryn hudsonHealth systemsCompany secretaryPrnewswire indiviorOpiant pharmaceuticals incAnnual net revenue potentialScalable business outlinedStrong net revenue growthOperating margin expansion overCapital allocationCapital markets dayChief executive officerOrganized health systems

Richmond-area-based pharma company Indivior buys NARCAN developer Opiant, aims to launch new overdose reversal agent

Richmond, VA, (Richmond Times Dispatch) – Chesterfield-based Indivior, already in the business of opioid addiction treatment, is branching into overdose protection.

United statesIndivior mark crossleyOpiant pharmaceuticals incRichmond times dispatchChesterfield based indiviorOpiant pharmaceuticalsMark crossleyTrack designationRoger crystalMerger and acquisitionDrug overdoseDrug rehabilitationOpioid antagonistsPsychoactive drugs

Indivior To Acquire Opiant Pharmaceuticals

/PRNewswire/ Indivior PLC (LON: INDV) ("Indivior" or the "Company") and Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) ("Opiant") today announced that the.

United statesMark crossleyKathryn hudsonCenters for diseaseDevelopment agencyNational institute on drug abuseNational institutes of healthEmergent biosolutions incLatham watkinsOpiant pharmaceuticals incCommittee on foreign investmentCovington burlingCompany secretaryHealth systemsPrnewswire indiviorAcquisition strengthens

Indivior Announces Q3 2022 Financial Results

/PRNewswire/ Indivior PLC (LON: INDV) today announced its financial results for the period ending September 30, 2022. The earnings release, investor.

United kingdom

vimarsana © 2020. All Rights Reserved.